| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A phase II trial with rosiglitazone in liposarcoma patients. | Br J Cancer | 2003 | 1.31 |
| 2 | The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells. | Am J Pathol | 2001 | 1.13 |
| 3 | Real-time reverse transcription-PCR and fluorescence in-situ hybridization are complementary to understand the mechanisms involved in HER-2/neu overexpression in human breast carcinomas. | Histopathology | 2005 | 0.96 |
| 4 | V(H) gene analysis of hairy cell leukemia reveals a homogeneous mutation status and suggests its marginal zone B-cell origin. | Leukemia | 2004 | 0.86 |